v3.24.2
REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)
 6 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Changes in Contract Assets and Contract Liabilities
The following table summarizes the changes in the contract asset and liability balances for the six months ended June 30, 2024:
Dollars in thousandsTotal
Contract Asset
Contract asset, January 1, 2024
$9,233 
Transferred to trade receivable from contract asset included in beginning of the year contract asset(9,233)
Contract asset, net of transferred to trade receivables on contracts during the period6,623 
Contract asset, June 30, 2024
$6,623 
Contract Liability
Contract liability, January 1, 2024
$16,252 
Recognition of revenue included in beginning of year contract liability(5,365)
Contract liability, net of revenue recognized on contracts during the period7,519 
Foreign currency translation(77)
Contract liability, June 30, 2024
$18,329 
Schedule of Disaggregation of Revenue
The following table presents revenues disaggregated by the major sources of revenues for the three and six months ended June 30, 2024 and 2023 (dollar amounts in thousands):
Three Months Ended June 30, 2024Three Months Ended June 30, 2023Six Months Ended June 30, 2024Six Months Ended June 30, 2023
Neurosurgery$205,502 $205,803 $407,770 $398,673 
Instruments54,537 56,365 98,910 102,603 
ENT(1)
41,722 8,862 51,515 17,890 
Total Codman Specialty Surgical301,761 271,030 558,195 519,166 
Wound Reconstruction and Care87,695 91,118 168,572 192,058 
Private Label28,719 19,119 60,280 50,889 
Total Tissue Technologies116,414 110,237 228,852 242,947 
Total revenue$418,175 $381,267 $787,047 $762,113 
(1) Prior period revenues included within our instruments business have been reclassified under the ENT business.